Heart Transplant Using Hepatitis C-Seropositive and Viremic Organs in Seronegative Recipients

12 June 2020 : Original article

Yuanjia Zhu^{ABCDEF 1}, Yasuhiro Shudo^{ADEF 1}, Roy Lee^{DEF 2,3}, Y. Joseph Woo^{ADEFG 1*}

DOI: 10.12659/AOT.922723

Ann Transplant 2020; 25:e922723

Related articles Order reprints Share article Share by email

View HTML version

Supplementary Table 1 Recipients and donors’ demographics.

Patient	Year of surgery	Recipient age (years); gender	Recipient ethnicity	Recipient height (cm)	Recipient weight (kg)	Donor age (years); Gender	Donor Ethnicity	Donor Height (cm)	Donor Weight (kg)	HCV NAT
1	1997	62; Male	Caucasian	160	63.5	50; Female	Caucasian	154.9	73	–
2	1997	52; Female	African American	165	81.7	15; Female	Hispanic	173	72	–
3	1998	56; Male	Asian	173	70	40; Male	Hispanic	168	65	–
4	2002	58; Male	Caucasian	180.3	90.7	44; Male	Caucasian	180	102	–
5	2010	57; Male	African American	172.7	93.9	51; Male	Caucasian	188	95	–
6	2015	60; Male	Caucasian	177.8	94.8	33; Male	Hispanic	177.8	101.5	Negative
7	2017	33; Male	Hispanic	170.2	72.1	33; Male	African American	183	94.2	Positive
8	2017	55; Female	Caucasian	167.6	78	54; Male	Caucasian	170	59	Positive
9	2019	59; Male	Caucasian	170	63.3	55; Female	Caucasian	159	67.8	Negative
10	2019	62; Male	Caucasian	180	85.4	33; Male	Caucasian	176	67.9	Positive
HCV – hepatitis C virus, NAT – nucleic acid testing.

Back to the Article